The Effectiveness of Interventions Targeting Self-Perception of Aging in Older Adults with Subjective Cognitive Decline
1 other identifier
interventional
64
1 country
1
Brief Summary
Subjective cognitive decline (SCD) represents the initial clinical manifestation in the disease spectrum of Alzheimer's Disease (AD). It represents an essential stage for early prevention and treatment of cognitive impairment, making the SCD population an optimal target for prior intervention. This study aims to assess the feasibility and efficacy of an 8-week intervention targeting self-perception of aging in community-dwelling older adults with SCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2024
CompletedFirst Posted
Study publicly available on registry
October 2, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedNovember 29, 2024
November 1, 2024
8 months
September 27, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective Cognitive Decline
The 9-item Subjective Cognitive Decline Questionnaire (SCD-Q9) consists of 9 items. Higher scores indicate a greater likelihood of subjective cognitive impairment.
Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)
Secondary Outcomes (4)
Cognitive Function
Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)
Self-perception of Aging
Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)
Perceived Stress
Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)
Coping Strategies
Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)
Other Outcomes (3)
Satisfaction questionnaire
8 weeks (post-intervention)
Compliance
8 weeks (post-intervention)
Acceptability interview
8 weeks (post-intervention)
Study Arms (2)
8-week intervention targeting self-perception of aging
EXPERIMENTALParticipants in this condition will receive an 8-week intervention targeting self-perception of aging. Group sessions will be held at community health service centers, with one session per week, each lasting 45 to 60 minutes. Additionally, homework assignments will be supplemented, and researchers will provide additional remote support via WeChat.
Controls
NO INTERVENTIONInterventions
The intervention program aims to help older adults with subjective cognitive decline understand the aging process and adopt a positive attitude toward aging, highlighting age-related benefits. The sessions also provide emotion regulation techniques and stress-coping strategies to encourage proactive problem-solving and build confidence in handling challenges. By recalling positive life experiences, the program seeks to strengthen emotional connections, enhance the sense of belonging, and reconstruct a meaningful later life.
Eligibility Criteria
You may qualify if:
- aged ≥60 years;
- residing in the community for 6 months at least;
- experiencing a consistent decline in self-reported cognitive abilities;
- having standard cognitive test performance in the normal range;
- willing to participate in this study.
You may not qualify if:
- having diagnosis of any neurological diseases including Parkinson's disease, brain tumor, cerebral infarction, encephalitis, epilepsy, etc.;
- having diagnosis of mental illness such as depression, anxiety, bipolar disorder, and schizophrenia;
- with history of substance abuse or addiction;
- with severe visual or hearing impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zheng Lilead
Study Sites (1)
School of Nursing, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, 100144, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 27, 2024
First Posted
October 2, 2024
Study Start
November 1, 2024
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
November 29, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share